1. Home
  2. CDMO

CDMO

Avid Bioservices Inc.

Logo Avid Bioservices Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Founded: 1981 Country:
United States
United States
Employees: N/A City: TUSTIN
Market Cap: 404.1M IPO Year: N/A
Target Price: $12.25 AVG Volume (30 days): 1.3M
Analyst Decision: Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.17 EPS Growth: N/A
52 Week Low/High: $4.07 - $21.04 Next Earning Date: 04-30-2024
Revenue: $140,938,000 Revenue Growth: 5.03%
Revenue Growth (this year): -5.25% Revenue Growth (next year): 19.39%

Share on Social Networks:

Stock Insider Trading Activity of Avid Bioservices Inc. (CDMO)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Hancock Richard B CDMO Director Dec 14 '23 Buy $5.86 23,000 $134,734.00 78,760 SEC Form 4